Medical Properties Trust (NYSE:MPW – Get Rating) issued an update on its FY 2022 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $1.78-$1.82 for the period. The company issued revenue guidance of -.
MPW opened at $17.90 on Tuesday. The company has a 50-day moving average of $20.01 and a 200-day moving average of $21.28. The company has a market capitalization of $10.67 billion, a P/E ratio of 9.57, a PEG ratio of 1.53 and a beta of 0.65. Medical Properties Trust has a 1-year low of $17.58 and a 1-year high of $24.13. The company has a debt-to-equity ratio of 1.13, a quick ratio of 3.99 and a current ratio of 1.64.
Medical Properties Trust (NYSE:MPW – Get Rating) last released its earnings results on Thursday, April 28th. The real estate investment trust reported $1.05 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.58. The company had revenue of $409.80 million during the quarter, compared to the consensus estimate of $413.31 million. Medical Properties Trust had a net margin of 70.61% and a return on equity of 13.25%. The company’s revenue was up 13.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.42 EPS. As a group, sell-side analysts expect that Medical Properties Trust will post 1.83 earnings per share for the current fiscal year.
Several research analysts have recently commented on MPW shares. Truist Financial decreased their price target on shares of Medical Properties Trust from $26.00 to $23.00 and set a hold rating for the company in a report on Thursday, March 24th. Jefferies Financial Group lowered shares of Medical Properties Trust from a buy rating to a hold rating and reduced their target price for the company from $25.00 to $20.00 in a research note on Friday, April 22nd. Mizuho boosted their target price on shares of Medical Properties Trust from $23.00 to $26.00 in a research note on Thursday, January 20th. StockNews.com started coverage on shares of Medical Properties Trust in a research note on Thursday, March 31st. They set a hold rating for the company. Finally, Bank of America lowered shares of Medical Properties Trust from a buy rating to a neutral rating and set a $21.00 target price for the company. in a research note on Friday, March 11th. Six equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of Buy and a consensus target price of $23.10.
In related news, CEO Edward K. Aldag, Jr. sold 615,000 shares of the stock in a transaction dated Wednesday, March 30th. The shares were sold at an average price of $21.33, for a total transaction of $13,117,950.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO R Steven Hamner sold 285,000 shares of the stock in a transaction dated Thursday, April 7th. The stock was sold at an average price of $21.04, for a total transaction of $5,996,400.00. Following the sale, the chief financial officer now directly owns 1,961,214 shares in the company, valued at approximately $41,263,942.56. The disclosure for this sale can be found here. Insiders sold a total of 906,000 shares of company stock worth $19,235,910 over the last quarter. Insiders own 1.04% of the company’s stock.
Large investors have recently modified their holdings of the business. Wells Fargo & Company MN boosted its stake in shares of Medical Properties Trust by 4.8% in the 4th quarter. Wells Fargo & Company MN now owns 1,847,571 shares of the real estate investment trust’s stock valued at $43,659,000 after purchasing an additional 85,175 shares during the last quarter. Paradigm Financial Partners LLC bought a new position in shares of Medical Properties Trust in the 4th quarter valued at about $238,000. Comerica Bank boosted its stake in shares of Medical Properties Trust by 35.5% in the 4th quarter. Comerica Bank now owns 392,895 shares of the real estate investment trust’s stock valued at $8,883,000 after purchasing an additional 102,937 shares during the last quarter. NewEdge Advisors LLC acquired a new stake in shares of Medical Properties Trust in the 4th quarter valued at approximately $1,169,000. Finally, Goldman Sachs Group Inc. raised its position in shares of Medical Properties Trust by 27.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 2,554,063 shares of the real estate investment trust’s stock valued at $60,352,000 after acquiring an additional 549,150 shares during the period. 82.27% of the stock is currently owned by hedge funds and other institutional investors.
Medical Properties Trust Company Profile (Get Rating)
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis.
- Get a free copy of the StockNews.com research report on Medical Properties Trust (MPW)
- Shopify (NYSE: SHOP) Approaches Key Support Level
- Follow The Money To Cigna
- Intuitive Surgical is an Intuitive Buy
- The Low In Lordstown Motors May Not Be The Last
- MarketBeat Podcast: Barbell Strategy To Strengthen Your Portfolio
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.